Current SGC Pharma Members provide funding and collaborate on scientific research without retaining intellectual property rights or advanced knowledge of outputs.
Explore our official press releases to stay updated on our major accomplishments and new partnerships. Want to be the first to know about the latest news from SGC?
Read about the latest breakthroughs, awards and ongoing work from the SGC. Discover how our work is making a global impact and driving forward the field of drug discovery. Interested in getting first the latest news from SGC?
The Structural Genomics Consortium (SGC) is strongly committed to equity, diversity, and inclusion. We strive to create an environment that welcomes individuals from all groups, countries, organizations and institutions in our research community. With the mission of creating global access to drug discovery through open science, SGC also endeavours to further the diversity of ideas and approaches in the workplace.
In this unique project, pharmaceutical companies and leading academic laboratories make their innovative high-quality chemical probes available to the research community through the SGC. These donated probes complement the probes generated by the SGC and its collaborators. All compounds accepted into the donated probes program meet the chemical probe quality criteria and have been evaluated by an internal as well as an external expert committee. Moreover, several probes are suitable for in vivo use. Control compounds are also provided and profiled.
SGC chemical probes are open-access reagents that are meant to be used by the biomedical research community with no restrictions on use. SGC-developed probes are complemented by a growing set of donated high-quality chemical probes developed in industry and non-SGC laboratories. These are also available for unencumbered use.
This policy (the “Privacy Policy”) applies to information that personally identifies you (“You”) (other than publicly available information) (“personal information”), that is collected by SGC, a company limited by guarantee (Company No. 4714553) and registered as a charity in England and Wales (Charity No. 1097737) (“SGC”), including on www.thesgc.org or any other SGC web properties (together, the “Website”), or that is otherwise provided by You to SGC.
IMPORTANT! YOUR ACCESS TO, USE OF, OR REGISTRATION ON WWW.THESGC.ORG OR ANY OTHER SGC WEB PROPERTIES (TOGETHER, THE “WEBSITE”), OR YOUR PROVISION TO SGC OF ANY CONTENT OR PERSONAL INFORMATION VIA THE WEBSITE, CONSTITUTES YOUR ACCEPTANCE OF, AND IS CONDITIONAL UPON YOUR ACCEPTANCE OF AND COMPLIANCE WITH, THESE TERMS AND CONDITIONS, INCLUDING THE SGC PRIVACY POLICY (THE “PRIVACY POLICY”), ALL AS AMENDED FROM TIME TO TIME. CAREFULLY READ ALL OF THE FOLLOWING TERMS AND CONDITIONS AND THE PRIVACY POLICY BEFORE PROCEEDING.
The Structural Genomics Consortium is committed to providing an accessible web presence. We want as many people as possible to be able to use this website. For example, that means you should be able to: